Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway
Xinjian Xu, Ji Lv, Fang Guo, Jing Li, Yitao Jia, Da Jiang, Na Wang, Chao Zhang, Lingyu Kong, Yabin Liu, Yanni Zhang, Jian Lv, Zhongxin Li
Share & cite
Links open in a new tab.
Citation record
- Year
- 2020
- Journal
- Frontiers in Microbiology
- WikiBiome key
xu-2020-gut-microbiome-pd1-mss-crc-metabolic-pathway
Used in 3 visible records
microbeBacteroidales→mechanismFarnesoid X Receptor (FXR)→diseaseColorectal Cancer→Researcher discussion
0 postsConnect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Transparent record
0 eventsActivity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
No public collaboration activity has been recorded for this page yet.
